Virtual Reality and Diagnostic of Attention Deficit Hyperactivity Disorder (ADHD) (PADA1)
NCT ID: NCT04561713
Last Updated: 2025-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2020-07-21
2022-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children
NCT03436017
fNIRS-Based Neurofeedback Training in Children With ADHD: The Effects of VR
NCT06743763
fNIRS Neurofeedback Training Using Virtual Reality in Children With ADHD
NCT05906485
Virtual Reality Treatment for Emerging Adults With ADHD
NCT06454604
Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity
NCT02217371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention Deficit Hyperactivity Disorder (ADHD)
Children aged 8 to 12 diagnosed with ADHD
Virtual reality task
Virtual reality application in an immersive room (CAVE) in three dimensions to assess child's sustained attention in a dynamic environment that is as close as possible to everyday situations.
Control
Control group of healthy ADHD children matched in age, gender and laterality to children in ADHD group
Virtual reality task
Virtual reality application in an immersive room (CAVE) in three dimensions to assess child's sustained attention in a dynamic environment that is as close as possible to everyday situations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality task
Virtual reality application in an immersive room (CAVE) in three dimensions to assess child's sustained attention in a dynamic environment that is as close as possible to everyday situations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children aged 8 to 12 diagnosed with ADHD (according to DSM-V criteria)
* Positive ADHD diagnosis with standardized maintenance of Kiddie-Sads
* Naïve drug treatment for ADHD
* Schooled in a classic environment
* Intellectual Quotient\> 80 (4 subtests of WASI, or WISC IV-R / WISC-V less than 2 years old)
* Having French as mother tongue
* Children benefiting from a social security scheme
* Signing of free, informed and written consent by the child and the holders of parental authority Group of children controls
Children aged 8 to 12 years undiagnosed ADHD (according to DSM-V criteria) :
* Not presenting with ADHD at standardized maintenance Kiddie-Sads
* Schooled in a classic environment
* Intellectual Quotient\> 80 (4 subtests of WASI)
* Having French as mother tongue
* Children benefiting from a social security scheme
* Signing of free, informed and written consent by the child and the holders of parental authority
Exclusion Criteria
* Presenting a hearing or vision diagnosis diagnosed that does not allow the task to be performed in virtual reality
* Neurological disorders
* Photosensitive Epilepsy (contraindication to immersion in virtual reality)
* Treatment with psychostimulants or other psychotropic drugs
* Unable to complete the virtual reality task during the familiarization session
8 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Arthur MICOULAUD-FRANCHI
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/33
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.